Trial · NCT04010955
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
NCT04010955, Active not recruiting, Asan Medical Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON). Trials, record NCT04010955. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04010955
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
- NCT number
- NCT04010955
- Status
- Active not recruiting
- Enrollment
- 1,200 participants, estimated
- Lead sponsor
- Asan Medical Center
- Conditions
- Acute Ischemic Stroke, Atrial Fibrillation, Extracranial Atherosclerosis, Intracranial Atherosclerosis, Coronary Artery Atherosclerosis, Peripheral Artery Stenosis, Anticoagulant, Antiplatelet
- Interventions
- Edoxaban Monotherapy
- First posted
- 2019-07-08
- Last updated
- 2025-07-11
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | MACE (major adverse cardiac event) | 18 months | Duration for first occurrence of major cardiovascular events after patient registration: ischemic stroke, hemorrhagic stroke, myocardial infarction, vascular death |
| Secondary | Hemorrhagic stroke | 18 months | Duration for first occurrence of hemorrhagic stroke after patient registration |
| Secondary | Stroke | 18 months | Duration for first occurrence of stroke (ischemic and hemorrhagic) after patient registration |
| Secondary | Acute Myocardial Infarction | 18 months | Duration for first occurrence of acute myocardial infarction after patient registration |
| Secondary | Major bleeding | 18 months | Duration for occurrence of major bleeding based on ISTH( International Society on Thrombosis and Haemostasis) after patient registration |
| Secondary | Vascular death | 18 months | Duration for first occurrence of vascular death after patient registration |
| Secondary | Ischemic stroke | 18 months | Duration for first occurrence of ischemic stroke after patient registration |
| Secondary | Net clinical benefit based on reduction in major adverse cardiac event compared to major bleeding events | 18 months | Net clinical benefit based on reduction in major adverse cardiac event compared to major bleeding events |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers15
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04010955
GET https://conductscience.org/api/trials/v1/NCT04010955/registered